問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Linkou Chang Gung Medical Foundation
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2018-10-01 - 2022-12-31
Condition/Disease
Nasopharyngeal Carcinoma
Test Drug
Pembrolizumab (MK3475)
Participate Sites8Sites
Recruiting5Sites
Terminated3Sites
2018-09-01 - 2022-12-31
Hepatocellular Carcinoma (HCC)
nivolumab﹝Opdivo﹞/ ipilimumab ﹝Yervoy﹞
Participate Sites9Sites
Recruiting8Sites
2021-03-02 - 2024-06-16
Participate Sites5Sites
Terminated5Sites
2020-08-01 - 2022-07-31
Participate Sites3Sites
Recruiting3Sites
2023-04-12 - 2028-04-12
Participate Sites1Sites
Recruiting1Sites
2022-08-01 - 2025-07-31
2018-08-01 - 2023-07-31
Participate Sites2Sites
Recruiting2Sites
2019-04-01 - 2025-12-31
Alzheimer’s disease
F-18 AV-45
2019-09-01 - 2020-08-31
Terminated1Sites
2009-08-01 - 2011-07-31
全部
